Literature DB >> 35562096

Annexin A protein family in atherosclerosis.

Yong-Zhen Li1, Yan-Yue Wang1, Liang Huang2, Yu-Yan Zhao1, Lin-Hui Chen1, Chi Zhang3.   

Abstract

Atherosclerosis, a silent chronic vascular pathology, is the cause of the majority of cardiovascular ischaemic events. Atherosclerosis is characterized by a series of deleterious changes in cellularity, including endothelial dysfunction, transmigration of circulating inflammatory cells into the arterial wall, pro-inflammatory cytokines production, lipid accumulation in the intima, vascular local inflammatory response, atherosclerosis-related cells apoptosis and autophagy. Proteins of Annexin A (AnxA) family, the well-known Ca2+ phospholipid-binding protein, have many functions in regulating inflammation-related enzymes and cell signaling transduction, thus influencing cell adhesion, migration, differentiation, proliferation and apoptosis. There is now accumulating evidence that some members of the AnxA family, such as AnxA1, AnxA2, AnxA5 and AnxA7, play major roles in the development of atherosclerosis. This article discusses the major roles of AnxA1, AnxA2, AnxA5 and AnxA7, and the multifaceted mechanisms of the main biological process in which they are involved in atherosclerosis. Considering these evidences, it has been proposed that AnxA are drivers- and not merely participator- on the road to atherosclerosis, thus the progression of atherosclerosis may be prevented by targeting the expression or function of the AnxA family proteins.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Annexin A; Apoptosis; Atherosclerosis; Autophagy; Inflammation

Mesh:

Substances:

Year:  2022        PMID: 35562096     DOI: 10.1016/j.cca.2022.05.009

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Usability of serum annexin A7 as a biochemical marker of poor outcome and early neurological deterioration after acute primary intracerebral hemorrhage: A prospective cohort study.

Authors:  Chuan-Liu Wang; Yan-Wen Xu; Xin-Jiang Yan; Cheng-Liang Zhang
Journal:  Front Neurol       Date:  2022-08-08       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.